O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.89B
AUM Growth
+$717M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
126
New
Increased
Reduced
Closed

Top Buys

1
+$41.7M
2
+$37.3M
3
+$33.5M
4
HELP
Cybin Inc
HELP
+$24.7M
5
BRKR icon
Bruker
BRKR
+$23.5M

Top Sells

1
+$125M
2
+$65.8M
3
+$51.6M
4
AXSM icon
Axsome Therapeutics
AXSM
+$38.9M
5
SIBN icon
SI-BONE Inc
SIBN
+$38M

Sector Composition

1 Healthcare 99.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
101
PTC Therapeutics
PTCT
$5.47B
$1.76M 0.04%
+23,200
MPLT
102
MapLight Therapeutics
MPLT
$784M
$952K 0.02%
+56,000
TRAW icon
103
Traws Pharma
TRAW
$13.2M
$684K 0.01%
605,531
ABT icon
104
Abbott
ABT
$202B
– –
0
AKRO
105
DELISTED
Akero Therapeutics
AKRO
– –
-526,200
AMLX icon
106
Amylyx Pharmaceuticals
AMLX
$1.67B
– –
-750,600
ATAI icon
107
AtaiBeckley Inc
ATAI
$1.32B
– –
-347,000
AZN icon
108
AstraZeneca
AZN
$323B
– –
0
IMTX icon
109
Immatics
IMTX
$1.39B
– –
-466,601
ITGR icon
110
Integer Holdings
ITGR
$2.98B
– –
-290,000
KRRO icon
111
Korro Bio
KRRO
$114M
– –
-32,400
KZR icon
112
Kezar Life Sciences
KZR
$49.1M
– –
-192,700
LYEL icon
113
Lyell Immunopharma
LYEL
$510M
– –
-51,727
MIST icon
114
Milestone Pharmaceuticals
MIST
$146M
– –
-3,221,828
MURA
115
DELISTED
Mural Oncology
MURA
– –
-588,800
PASG icon
116
Passage Bio
PASG
$29M
– –
-59,046
SCPH
117
DELISTED
scPharmaceuticals
SCPH
– –
-6,059,528
SIBN icon
118
SI-BONE Inc
SIBN
$673M
– –
-2,578,979
SRRK icon
119
Scholar Rock
SRRK
$4.52B
– –
0
TGTX icon
120
TG Therapeutics
TGTX
$4.78B
– –
0
VSTM icon
121
Verastem
VSTM
$431M
– –
-887,561
XERS icon
122
Xeris Biopharma Holdings
XERS
$1.02B
– –
-80,420
DHAI
123
DELISTED
DIH Holdings US
DHAI
– –
-76,600
1 2 3 4
5